Weekly Digest – October 2026 Weekly Digest – October 2026 15 October 2026: Adlai Nortye partnered with Lilly and Merck KGaA to evaluate AN4035 in combination with cetuximab Adlai Nortye has entered clinical trial collaboration and supply agreements with Eli […]